Targeting EZH2 reactivates a breast cancer subtype-specific anti-metastatic transcriptional program
2018 · Nature Communications · 82 citations
https://doi.org/10.1038/s41467-018-04864-8
C
Catherine R. Dufour
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
119
Papers
3.2K
Citations
25
h-index
34
i10-index
Catherine R. Dufour is an academic researcher from McGill University Health Centre. The author has contributed to research in topics: Prostate Cancer Treatment and Research & RNA modifications and cancer & PI3K/AKT/mTOR signaling in cancer. The author has an h-index of 25, co-authored 102 publications.
ORCID: 0000-0001-7324-3458Papers by this author
worksInhibition of DNMT1 and ERRα crosstalk suppresses breast cancer via derepression of IRF4
2020 · Oncogene · 44 citations
https://doi.org/10.1038/s41388-020-01438-1
An ErbB2/c-Src axis links bioenergetics with PRC2 translation to drive epigenetic reprogramming and mammary tumorigenesis
2019 · Nature Communications · 41 citations
https://doi.org/10.1038/s41467-019-10681-4
Estrogen-related receptor alpha (ERRα) is a key regulator of intestinal homeostasis and protects against colitis
2021 · Scientific Reports · 24 citations
https://doi.org/10.1038/s41598-021-94499-5
Impact of eIF2α phosphorylation on the translational landscape of mouse embryonic stem cells
2023 · Cell Reports · 20 citations
https://doi.org/10.1016/j.celrep.2023.113615
ERBB2 Deficiency Alters an E2F-1-Dependent Adaptive Stress Response and Leads to Cardiac Dysfunction
2014 · Molecular and Cellular Biology · 15 citations
https://doi.org/10.1128/mcb.00895-14
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat